|
|
|
|
|
|
May 2007 » FDA sanctions first low dose combination oral contraceptive pill, Lybrel May 23, 2007 The much awaited oral contraceptive lybrel
finally gets the Food and Drug Administration nod to offer complete relief
to women who seek oral contraceptive for the deterrence of pregnancy and
have no issues with the newly approved preparation. Wyeth Pharmaceuticals's
innovation, lybrel is approved to be utilized as an oral contraceptive
for the prevention of pregnancy in women. The drug is the only and first
low dose combination contraceptive preparation which can be consumed the
whole year, i.e., 365 days a year without any gap. A prescription formulation,
lybrel is anticipated to hit U.S. pharmacies in July 2007. |